L L Davis

Summary

Country: USA

Publications

  1. pmc Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial
    Lori L Davis
    VA Medical Center, Tuscaloosa, Alabama 35404, United States
    Depress Anxiety 29:111-22. 2012
  2. ncbi request reprint A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans
    Lori L Davis
    University of Alabama School of Medicine, Birmingham, AL, USA
    Psychopharmacol Bull 41:8-18. 2008
  3. ncbi request reprint Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort
    Lori L Davis
    VA Medical Center, Tuscaloosa, AL 35404, USA
    Compr Psychiatry 46:81-9. 2005
  4. ncbi request reprint Divalproex sodium in the treatment of adults with bipolar disorder
    Lori L Davis
    University of Alabama at Birmingham, Birmingham, AL, USA
    Expert Rev Neurother 4:349-62. 2004
  5. ncbi request reprint A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study
    Lori L Davis
    VA Medical Center 151, 3701 Loop Road East, Tuscaloosa, AL 35404, USA
    J Clin Psychopharmacol 24:291-7. 2004
  6. ncbi request reprint Pharmacotherapy for post-traumatic stress disorder: a comprehensive review
    L L Davis
    Veterans Affairs Medical Center, 3701 Loop Road East, Tuscaloosa, Alabama 35404, USA
    Expert Opin Pharmacother 2:1583-95. 2001
  7. ncbi request reprint Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort
    Lori L Davis
    VA Medical Center, Tuscaloosa, AL 35404, USA
    Am J Addict 15:278-85. 2006
  8. ncbi request reprint Divalproex in the treatment of bipolar depression: a placebo-controlled study
    Lori L Davis
    Veteran s Affairs Medical Center 151, 3701 Loop Road East, Tuscaloosa, AL 35404, USA
    J Affect Disord 85:259-66. 2005
  9. ncbi request reprint Nefazodone treatment for chronic posttraumatic stress disorder: an open trial
    L L Davis
    Department of Veterans Affairs Medical Center at Tuscaloosa, Alabama 35404, USA
    J Clin Psychopharmacol 20:159-64. 2000
  10. ncbi request reprint Comprehensive review of the psychiatric uses of valproate
    L L Davis
    Veteran s Affairs Medical Center, Tuscaloosa, Alabama 35404, USA
    J Clin Psychopharmacol 20:1S-17S. 2000

Detail Information

Publications24

  1. pmc Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial
    Lori L Davis
    VA Medical Center, Tuscaloosa, Alabama 35404, United States
    Depress Anxiety 29:111-22. 2012
    ..These patients are often excluded from clinical trials, resulting in a significant knowledge gap regarding optimal pharmacotherapy for the treatment of MDD with concurrent SUD...
  2. ncbi request reprint A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans
    Lori L Davis
    University of Alabama School of Medicine, Birmingham, AL, USA
    Psychopharmacol Bull 41:8-18. 2008
    ..This study tests the ability of the a(2) adrenergic agonist, guanfacine, to reduce the symptoms of PTSD...
  3. ncbi request reprint Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort
    Lori L Davis
    VA Medical Center, Tuscaloosa, AL 35404, USA
    Compr Psychiatry 46:81-9. 2005
    ..In conclusion, gender, marital status, age of onset of major depression, functional impairment, and suicide risk factors differ in depressed patients with concurrent SUD symptoms compared to those without SUD comorbidity...
  4. ncbi request reprint Divalproex sodium in the treatment of adults with bipolar disorder
    Lori L Davis
    University of Alabama at Birmingham, Birmingham, AL, USA
    Expert Rev Neurother 4:349-62. 2004
    ..The use of divalproex in the treatment of bipolar and other related psychiatric disorders is reviewed...
  5. ncbi request reprint A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study
    Lori L Davis
    VA Medical Center 151, 3701 Loop Road East, Tuscaloosa, AL 35404, USA
    J Clin Psychopharmacol 24:291-7. 2004
    ..06). This pilot study supports the efficacy of nefazodone for the treatment of PTSD. However, larger placebo-controlled studies in more diverse patient population are warranted...
  6. ncbi request reprint Pharmacotherapy for post-traumatic stress disorder: a comprehensive review
    L L Davis
    Veterans Affairs Medical Center, 3701 Loop Road East, Tuscaloosa, Alabama 35404, USA
    Expert Opin Pharmacother 2:1583-95. 2001
    ..Also, there are virtually no data on pharmacotherapy for acute stress reaction or for PTSD in children. Future directions for research may focus on combination treatment in the more treatment-resistant patient populations...
  7. ncbi request reprint Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort
    Lori L Davis
    VA Medical Center, Tuscaloosa, AL 35404, USA
    Am J Addict 15:278-85. 2006
    ..048 to <0.0001). They were also less likely to be Hispanic and endorse general medical comorbidities (p = 0.006 and 0.002, respectively)...
  8. ncbi request reprint Divalproex in the treatment of bipolar depression: a placebo-controlled study
    Lori L Davis
    Veteran s Affairs Medical Center 151, 3701 Loop Road East, Tuscaloosa, AL 35404, USA
    J Affect Disord 85:259-66. 2005
    ..Thus, the potential antidepressant efficacy of mood stabilizers, such as divalproex, which is an effective treatment for the manic phase of bipolar disorder, is of considerable interest...
  9. ncbi request reprint Nefazodone treatment for chronic posttraumatic stress disorder: an open trial
    L L Davis
    Department of Veterans Affairs Medical Center at Tuscaloosa, Alabama 35404, USA
    J Clin Psychopharmacol 20:159-64. 2000
    ..In summary, nefazodone treatment improved the symptoms of PTSD, including the core symptoms. Placebo-controlled studies should be undertaken to further elucidate the efficacy of nefazodone in the treatment of PTSD...
  10. ncbi request reprint Comprehensive review of the psychiatric uses of valproate
    L L Davis
    Veteran s Affairs Medical Center, Tuscaloosa, Alabama 35404, USA
    J Clin Psychopharmacol 20:1S-17S. 2000
    ..The authors conclude with a brief summary of its mechanism of action and therapeutic spectrum...
  11. ncbi request reprint Growth hormone response to the GABAB agonist baclofen in major depressive disorder
    L L Davis
    Veterans Affairs Medical Center, Dallas, TX 75216, USA
    Psychoneuroendocrinology 22:129-40. 1997
    ..Age significantly correlated with GH response, with older subjects having lower GH response to baclofen. These data do not suggest that a blunted GH response to baclofen. represents a specific neuroendocrine feature of major depression...
  12. pmc Post-traumatic stress disorder and serotonin: new directions for research and treatment
    L L Davis
    Veterans Affairs Medical Center, Tuscaloosa, AL 35404, USA
    J Psychiatry Neurosci 22:318-26. 1997
    ..Further investigation of a serotonergic dysfunction in PTSD and of its treatment with serotonergic agents is warranted...
  13. ncbi request reprint Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder
    Marshall E Cates
    McWhorter School of Pharmacy, Samford University, Birmingham, AL 35229 7027, USA
    Ann Pharmacother 38:1395-9. 2004
    ..Clonazepam is widely used for the treatment of posttraumatic stress disorder (PTSD)-related sleep disturbances despite very limited published data supporting its use for this indication...
  14. doi request reprint Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390, USA
    Arch Gen Psychiatry 65:870-80. 2008
    ..Little is known about selecting among second-step medications for major depressive disorder after intolerance or lack of remission with an initial selective serotonin reuptake inhibitor...
  15. doi request reprint Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population
    Lori L Davis
    Veterans Affairs Medical Center, Tuscaloosa, AL 35404, USA
    J Clin Psychopharmacol 28:84-8. 2008
    ..To evaluate the efficacy of divalproex for the treatment of posttraumatic stress disorder (PTSD) hyperarousal symptom cluster...
  16. ncbi request reprint Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort
    Lori L Davis
    Department of Veterans Affairs VA Medical Center, Tuscaloosa, Ala 35404, USA
    J Clin Psychiatry 68:1931-8. 2007
    ....
  17. ncbi request reprint A pharmacokinetic and clinical evaluation of switching patients with bipolar I disorder from delayed-release to extended-release divalproex
    Lori L Davis
    Research and Development Department, Tuscaloosa VA Medical Center, Tuscaloosa, AL 35404, USA
    J Clin Psychiatry 68:1546-51. 2007
    ..To determine the optimal strategy for converting stable bipolar patients from twice-daily divalproex delayed release (DR) to once-daily divalproex extended release (ER)...
  18. ncbi request reprint Insured and non-insured depressed outpatients: how do they compare?
    Ira M Lesser
    Department of Psychiatry, Harbor UCLA Medical Center, The Los Angeles Biomedical Research Institute, Los Angeles, CA, USA
    Ann Clin Psychiatry 19:73-82. 2007
    ....
  19. ncbi request reprint Valproate therapy for chronic, combat-induced posttraumatic stress disorder
    Frederick Petty
    J Clin Psychopharmacol 22:100-1. 2002
  20. ncbi request reprint Long-term pharmacotherapy for post-traumatic stress disorder
    Lori L Davis
    VA Medical Center, Tuscaloosa, Alabama 35404, USA
    CNS Drugs 20:465-76. 2006
    ..The effect of other agents (atypical antipsychotics, AEDs and other psychotropic medications) requires further controlled study...
  21. ncbi request reprint Treatment of chronic posttraumatic stress disorder in combat veterans with citalopram: an open trial
    Brett A English
    Department of Pharmacology, Center for Molecular Neuroscience, Graduate Program in Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA
    J Clin Psychopharmacol 26:84-8. 2006
    ..Further study in a larger and more diverse patient sample is warranted prior to final conclusions on efficacy of citalopram for the treatment of PTSD...
  22. ncbi request reprint Baclofen treatment for chronic posttraumatic stress disorder
    Roger G Drake
    Clinical Pharmacy, Bryce Hospital, Tuscaloosa, AL, USA
    Ann Pharmacother 37:1177-81. 2003
    ..We hypothesized that baclofen, a GABA(B) agonist, would be an effective treatment in the symptomatic management of veterans with chronic posttraumatic stress disorder (PTSD)...
  23. pmc Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder
    Xiaohua Li
    Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294 0017, USA
    Biol Psychiatry 61:216-22. 2007
    ..We tested whether lithium modified GSK3beta in vivo or in vitro in peripheral blood mononuclear cells (PBMCs) from healthy control and bipolar disorder subjects...
  24. ncbi request reprint Characteristics of insured and noninsured outpatients with depression in STAR(*)D
    Ira M Lesser
    Harbor UCLA Medical Center, Box 8, 1000 West Carson Street, Torrance, California 90509, USA
    Psychiatr Serv 56:995-1004. 2005
    ....